Company: BSTZ
Filing Date: 2025-03-07
Form Type: N-CSR
Source: 0001193125-25-049659
Chunk: 47

Company: BlackRock Science & Technology Term Trust
Filing Date: 2025-03-07
Form: N-CSR
Chunk 47
---
44,936 |
| Gerresheimer AG                      | Bank of America N.A.                   |             16,300 | 02/06/25       | EUR            |  76.86 | EUR                  |  1,157 |      -16,740 |
| Roche Holding AG                     | BNP Paribas SA                         |             38,400 | 02/06/25       | CHF            | 253.66 | CHF                  |  9,811 |     -299,510 |
|                                      |                                        |                    |                |                |        |                      |        | $(1,750,135) |

Balances Reported in the Statements of Assets and Liabilities for Options Written

| Description     | PremiumsPaid | PremiumsReceived | UnrealizedAppreciation | UnrealizedDepreciation | Value         |
| Options Written | $N/A         | $(15,891,589)    |             $7,178,894 | $(1,728,275)           | $(10,440,970) |

Schedule of Investments 79

Schedule of Investments (continued) December 31, 2024 BlackRock Health Sciences Term Trust (BMEZ)

Derivative Financial Instruments Categorized by Risk Exposure As of period end, the fair values of derivative financial instruments located in the Statements of Assets and Liabilities were as follows:

|                                                | CommodityContracts | CreditContracts | EquityContracts | ForeignCurrencyExchangeContracts | InterestRateContracts | OtherContracts |       Total |
| Liabilities — Derivative Financial Instruments |                    |                 |                 |                                  |                       |                |             |
| Options writtenOptions written at value        | $—                 | $—              |     $10,440,970 | $—                               | $—                    | $—             | $10,440,970 |

For the period ended December 31, 2024, the effect of derivative financial instruments in the Statements of Operations was as follows:

|                                                          | CommodityContracts | CreditContracts | EquityContracts | ForeignCurrencyExchangeContracts | InterestRateContracts | OtherContracts |        Total |
| Net Realized Gain (Loss) from:                           |                    |                 |                 |                                  |                       |                |              |
| Forward foreign currency exchange contracts              | $—                 | $—              |              $— | $(3,753,243)                     | $—                    | $—             | $(3,753,243) |
| Options written                                          | —